Preview

Nephrology and Dialysis

Advanced search

Eosinophilic dialysis peritonitis. Cases report and literature review

https://doi.org/10.28996/2618-9801-2020-4-526-534

Abstract

Peritoneal dialysis (PD) is a widely used method of renal replacement therapy (RRT) in children with stage 5 chronic kidney disease (CKD). The most common complication of PD and the leading cause of hospitalization for these patients is dialysis peritonitis. The vast majority of cases of dialysis peritonitis are caused by microbial infection of the abdominal cavity and demands antibiotic therapy. Dialysis peritonitis resistant to antibacterial therapy leads to the removal of the peritoneal catheter, to the temporary or permanent transfer of the patient to hemodialysis. However, some cases of dialysis peritonitis not responding to antibiotic therapy are represented by a separate form - eosinophilic peritonitis (EP), in which more than 10% of the dialysate cells are eosinophils, and which requires special approaches to therapy. The article presents three cases of EP in children demonstrating characteristic features of this complication: in two of the three patients, EP appeared after repeated abdominal surgery, eosinophils predominated in the dialysate cell count (68-95%), and blood eosinophilia was observed. In no case, bacteria growth in repeated dialysate cultures was detected. In all patients, EP resolved with corticosteroid therapy. In one case, after stopping EP, bacterial dialysis peritonitis developed. In addition to dialysate culture, differential diagnosis between EP and bacterial peritonitis was carried out by leukocytes count in a stained dialysate smear. The review of publications provides information on the incidence of EP according to foreign researchers, on the pathogenesis, symptoms, diagnostic methods, and therapy of this condition. Idiopathic and secondary EP are considered. Idiopathic EP is facilitated by factors directly related to peritoneal dialysis: peritoneal catheter material, dialysis solution components (including icodextrin), air entering the abdominal cavity when the peritoneal catheter is inserted and exchanges are performed, and mechanical stress of the peritoneum caused by the dialysis solution. Secondary EP may develop with the use of various drugs intraperitoneally or orally, with local or systemic infection (fungal, mycobacterial, parasitic) Timely diagnosis of EP in PD patients prevents long-term “empirical” antibacterial therapy, associated with the risk of fungal peritonitis, unjustified removal of the peritoneal catheter, and maintains PD as the optimal dialysis method in children.

About the Authors

T. E. Pankratenko
St. Vladimir’s Children's City Clinical Hospital; Moscow Regional Research and Clinical Institute
Russian Federation


A. L. Muzurov
St. Vladimir’s Children's City Clinical Hospital; Russian Medical Academy of Postgraduate Education
Russian Federation


Kh. M. Emirova
St. Vladimir’s Children's City Clinical Hospital
Russian Federation


T. Yu. Abaseeva
St. Vladimir’s Children's City Clinical Hospital
Russian Federation


G. A. Generalova
St. Vladimir’s Children's City Clinical Hospital
Russian Federation


S. A. Mstislavskaya
Мoscow State Medical-Dental University
Russian Federation


References

1. Томилина Н.А., Андрусев А.М., Перегудова Н.Г., Шинкарев М.Б. Заместительная терапия терминальной хронической почечной недостаточности в Российской Федерации в 2010-2015 г.г; Нефрология и диализ; 2017(4, приложение к Т.19); с 1-95

2. United States Renal Data System. Annual data report, chapter 7. 2018; https://www.usrds.org/2018/view/v2_07.aspx

3. Chadha V, Franz S, Schaefer F S, Warady B A. Dialysis-associated peritonitis in children. Pediatr Nephrol, 2010; 25: 425-440

4. Ponce D, Proenca de Moraes T, Pecoits-Filho R, Figueiredo A E, Barretti P. Peritonitis in children on chronic peritoneal dialysis: the experience of a large national pediatric cohort. Blood Purif, 2018; 45:118-125

5. Li K-T F, Szeto C C, Piraino B, de Arteaga J, Fan S, Figueiredo A E et al. ISPD peritonitis recomendation: 2016 update on prevention and treatment. Peritoneal Dialysis International, 2016 (36): 481-508

6. Lee K O, Park S J, Kim J H, Lee J S, Kim P K, Shin J. Outcomes of peritonitis in children on peritoneal dialysis: a 25-year experience at severance hospital. Yonsei Med J, 2013; 54(4):983-989

7. Lee S, Schoen I. Eosinophilia of peritoneal fluid and peripheral blood associated with chronic peritoneal dialysis. Am J Clin Pathol, 1967, 638-640

8. Spinawitz B S, Golden R.A, Rascoff J H, Charytan C. Eosinophylic peritonitis. Clin. exper. dialysis and apheresis, 1982; 6(4): 187-191

9. Chan M K, Chow L, Lam S S, Jones B. Peritoneal Eosinophilia in patients on continuous ambulatory peritoneal dialysis: a prospective study. American journal of kidney diseases, 1988; 11(2): 180-183

10. Oh S Y, Kim H, Kang J M, Lim S H et al. Eosinophilic peritonitis in a patient with continuous ambulatory peritoneal dialysis (CAPD) The Korean journal of internal medicine,2004; 19 (2): 121-123

11. Fontan M P, Rodriguez-Carmona A, Galed I et al. Incidence and significance of peritoneal eosinophilia during peritoneal dialysis-related peritonitis Perit Dial Int. 2003; 23(5): 460-4. -11

12. Chiao-Hsin H, Li-Chuan C, Ling-Fang J et al. Incidence and clinical presentations of eosinophilic peritonitis in continuous ambulatory peritoneal dialysis patients: experience in a medical center. Acta Nephrologica, 2011; 25(1): 22-25,

13. Quinlan C, Cantwell M, Rees L. Eosinophilic peritonitis in children on chronic peritoneal dialysis. Pediatr Nephrol 2010; 25: 517-522

14. Albilali A S, Rahim K A, Edrees B M, Al Shaya H O. Resolution of eosinophilic peritonitis with oral prednisolone in a child receiving peritoneal dialysis/ Perit Dial Int, 2011; 31 (2): doi: 10. 3747/PDI 2010.00058

15. Hooman N, Jahangiry F, Asdaghi M, Ghafari L. Vancomycin induced eosinophilic peritonitis: A Case Report. J Ped. Nephrology, 2018; 6(1): http://journals.sbmu.ac.ir/jpn

16. Deweese R, Slavens J, Barua A, Sutton J Vancomycin-induced eosinophilic peritonitis Am J Health-Syst Pharm. 2016; 73:e243-246

17. Samuel B, Dylewski J, Agarwal A et al. Eosinophilic peritonitis - a clinical decision. Lab Medicine, 2013; 44 (3): е79, www.labmedicine.com

18. Dossin T, Goffin E. When the color of peritoneal dialysis effluent can be used as a diagnostic tool. Seminars in Dialysis. 2018; 1-8. DOI: 10.1111/sdi.12740

19. Tian X, Jingyuan X, Weiming W, Hong R, Nan C. Asymptomatic dialysate turbidity and repeated intraductal clots in a peritoneal dialysis patient. Biomed Hub 2019; 4: 500944, DOI: 10.1159/000500944

20. Shigemoto E, Mizuno M, Suzuki Y. Increase of eosinophil in dialysate during induction of peritoneal dialysis. Peritoneal Dialysis International, 2019; 39: 90-92

21. Cetin N, Melike Sav N, Ciftci E, Yildiz B. Foreign body reaction to dialysis chatheter and peritoneal fluid eosinophilia in a child on continuous ambulatory peritoneal dialysis. IJKD 2017; 11: 319-321

22. Minato S, Miyazawa H, Taisuke Kitano T et al. Eosinophilic peritonitis induced by sucroferric oxyhydroxide. Peritoneal Dialysis International, 2020: doi.org/10.1177/0896860820915019

23. Asim M. Eosinophilic peritonitis in a continuous ambulatory peritoneal dialysis patient: inflammation and irritation without infection. Saudi J Kidney Dis Transpl 2017; 28(2): 401-404

24. Yaowen X, Chenni G, Jing X, Nan C. Successful treatment of idiopathic eosinophilic peritonitis by oral corticosteroid therapy in a continuous ambulatory peritoneal dialysispPatient Case Rep Nephrol Dial, 2015; 5: 130-134 DOI: 10.1159/000431085


Review

For citations:


Pankratenko T.E., Muzurov A.L., Emirova Kh.M., Abaseeva T.Yu., Generalova G.A., Mstislavskaya S.A. Eosinophilic dialysis peritonitis. Cases report and literature review. Nephrology and Dialysis. 2020;22(4):526-534. (In Russ.) https://doi.org/10.28996/2618-9801-2020-4-526-534

Views: 55


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1680-4422 (Print)
ISSN 2618-9801 (Online)